NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $836,000 | +5.2% | 9,003 | -3.2% | 0.06% | -4.6% |
| Q1 2021 | $795,000 | -6.5% | 9,296 | +3.3% | 0.06% | -7.1% |
| Q4 2020 | $850,000 | -20.3% | 8,998 | -26.6% | 0.07% | -30.7% |
| Q3 2020 | $1,066,000 | -0.7% | 12,264 | -0.3% | 0.10% | -7.3% |
| Q2 2020 | $1,074,000 | +3.1% | 12,296 | -2.7% | 0.11% | -15.5% |
| Q1 2020 | $1,042,000 | +33.9% | 12,633 | +53.7% | 0.13% | +67.5% |
| Q4 2019 | $778,000 | +15.1% | 8,220 | +5.7% | 0.08% | +5.5% |
| Q3 2019 | $676,000 | -3.6% | 7,779 | +1.4% | 0.07% | -1.4% |
| Q2 2019 | $701,000 | -6.7% | 7,673 | -1.8% | 0.07% | -6.3% |
| Q1 2019 | $751,000 | +11.8% | 7,814 | -0.2% | 0.08% | -3.7% |
| Q4 2018 | $672,000 | +6.5% | 7,829 | +6.9% | 0.08% | +17.1% |
| Q3 2018 | $631,000 | +5.9% | 7,321 | -7.2% | 0.07% | +16.7% |
| Q2 2018 | $596,000 | -15.3% | 7,888 | -9.4% | 0.06% | -24.1% |
| Q1 2018 | $704,000 | -6.8% | 8,703 | -3.2% | 0.08% | -7.1% |
| Q4 2017 | $755,000 | – | 8,989 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |